| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |